Evaluating HRIG Dose Rounding and Vial Size Selection to Reduce Medication Waste and Costs in a Multi-State Healthcare System
by Jordan J. Weber, PharmD, Jennifer Vogel PharmD, BCPS, Killian Mielotz PharmD, BCPS
Abstract:
Background: Rabies is a fatal yet preventable viral disease, making timely administration of human rabies immune globulin (HRIG) essential for post-exposure prophylaxis. Current guidance from the Centers for Disease Control and Prevention, World Health Organization, Advisory Committee on Immunization Practices, and the Food and Drug Administration recommends a fixed HRIG dose of 20 IU/kg based on actual body weight. Within a large healthcare system, an opportunity has been identified to improve HRIG administration in the emergency department, as no standardized approach to dose rounding or vial size selection exists.
Methods: We conducted a multicenter retrospective analysis across the Midwest division (Wisconsin/Illinois) of a large healthcare system, evaluating patients who received HRIG between January 1 and December 31, 2024. The analysis assessed potential cost savings associated with dose rounding and evaluated vial size selection to support inventory standardization. A total of 700 HRIG orders were reviewed.
Results: Among 264 (37.7%) orders with appropriate vial sizes, dose rounding to the nearest vial size could have reduced waste by 64.22 mL, corresponding to an estimated $31,410 per year in cost savings. For 331 (47.3%) orders with non-optimal vial selection, standardizing to 1 mL vials could have saved an estimated $347,290 per year. All cost estimates are based on wholesale acquisition cost.
Conclusion: Standardizing HRIG dose rounding and vial size selection represents a significant opportunity to reduce waste, lower costs, and improve operational consistency across the healthcare system.
Download PDF
2026 November/December Table of Contents
Abstract:
Background: Rabies is a fatal yet preventable viral disease, making timely administration of human rabies immune globulin (HRIG) essential for post-exposure prophylaxis. Current guidance from the Centers for Disease Control and Prevention, World Health Organization, Advisory Committee on Immunization Practices, and the Food and Drug Administration recommends a fixed HRIG dose of 20 IU/kg based on actual body weight. Within a large healthcare system, an opportunity has been identified to improve HRIG administration in the emergency department, as no standardized approach to dose rounding or vial size selection exists.
Methods: We conducted a multicenter retrospective analysis across the Midwest division (Wisconsin/Illinois) of a large healthcare system, evaluating patients who received HRIG between January 1 and December 31, 2024. The analysis assessed potential cost savings associated with dose rounding and evaluated vial size selection to support inventory standardization. A total of 700 HRIG orders were reviewed.
Results: Among 264 (37.7%) orders with appropriate vial sizes, dose rounding to the nearest vial size could have reduced waste by 64.22 mL, corresponding to an estimated $31,410 per year in cost savings. For 331 (47.3%) orders with non-optimal vial selection, standardizing to 1 mL vials could have saved an estimated $347,290 per year. All cost estimates are based on wholesale acquisition cost.
Conclusion: Standardizing HRIG dose rounding and vial size selection represents a significant opportunity to reduce waste, lower costs, and improve operational consistency across the healthcare system.
Download PDF
2026 November/December Table of Contents